Press-release for stocks related to covid

Prices are updated after-hours

tags : Covid

save search

Todos Medical Announces Preprint of Data from First 100 Participants in IRB-waived Market Research Study of Supplementation with Tollovid in Long COVID
Published: 2022-08-19 (Crawled : 13:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M

Manufacturing

| -99.31% | O: 0.0% H: 10.42% C: 4.17%
research covid tollovid 100 study market

CARNIVAL CRUISE LINE SAYS BOOKING ACTIVITY NEARLY DOUBLES 2019 COMPARISON AFTER COVID PROTOCOLS SIMPLIFIED
Published: 2022-08-16 (Crawled : 17:00) - prnewswire.com
CUK | News | $12.73 -0.55% -0.47% 1.1M

Consumer Services

| 30.56% | O: -1.23% H: 6.75% C: 5.4%
CCL | News | $14.12 -0.42% 0.0% 29M

Consumer Services

| 31.84% | O: -0.75% H: 7.06% C: 5.27%
covid

MediciNova Reaches Agreement to Participate in Grant-Funded Clinical Trial to Evaluate MN-166 (ibudilast) for the Treatment of Long COVID
Published: 2022-08-16 (Crawled : 11:00) - globenewswire.com
MNOV | $1.395 -0.36% -0.36% 18K

Health Technology

| -43.95% | O: -1.21% H: 1.22% C: -0.41%
mn-166 treatment covid trial agreement

Todos Medical Reports Pre-Print of Publication Detailing Tollovid Supplementation Following COVID-19 mRNA Vaccination in Long COVID
Published: 2022-08-15 (Crawled : 14:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M

Manufacturing

| -99.37% | O: 1.59% H: 21.88% C: -12.5%
covid-19 covid mrna tollovid publication

Todos Medical Completes Trial Design for Tollovid™ Long COVID Clinical Study in Adults
Published: 2022-08-11 (Crawled : 13:20) - globenewswire.com
TOMDF | $0.0001 100.0% 14M

Manufacturing

| -99.33% | O: 17.06% H: 0.0% C: -9.14%
covid trial study

Lucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu Test
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
LHDX | $0.4523 -10.46% 0

| -81.46% | O: 11.26% H: 0.0% C: -5.06%
JBL S | $118.75 -8.37% 0.76% 3.3M

Electronic Technology

| 94.45% | O: 0.65% H: 1.37% C: 0.42%
covid test canada health authorization

Todos Medical Announces First Long COVID Clinic Laboratory Services Agreement for Long COVID Panel Biomarker Partnership with Amerimmune Diagnostics
Published: 2022-08-05 (Crawled : 18:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M

Manufacturing

| -99.11% | O: 8.89% H: 7.76% C: -12.65%
partnership covid services biomarker diagnostics agreement

Detecting Immunity to COVID just got a Whole Lot Easier
Published: 2022-08-03 (Crawled : 12:20) - prnewswire.com
CERS | $1.675 2.13% 2.09% 980K

Health Technology

| -70.11% | O: 1.42% H: 2.98% C: 2.28%
covid

Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
Published: 2022-08-02 (Crawled : 11:00) - biospace.com/
AXLA | $4.58 -56.33% 42K

Health Technology

| 136.08% | O: 4.12% H: 6.93% C: 0.5%
covid trial phase 2b

Ubiquitome's Liberty16 Pro ready to carve up next COVID wave
Published: 2022-07-28 (Crawled : 13:00) - prnewswire.com
PPRUF | $358.55 37.56% 1.5K

Consumer Non-Durables

| -32.77% | O: 3.93% H: 4.27% C: 2.89%
PPRUY | $36.0023 -0.11% 220K

Manufacturing

| -32.6% | O: 4.07% H: 2.51% C: 2.41%
covid ready

Todos Medical Partners with Amerimmune Diagnostics on Long COVID Biomarker Panel
Published: 2022-07-28 (Crawled : 12:00) - biospace.com/
TOMDF | $0.0001 100.0% 14M

Manufacturing

| -98.32% | O: -3.36% H: 4.35% C: 3.48%
covid biomarker diagnostics

Todos Medical Announces Preprint of Chronic Long COVID Case Study #8 of Paxlovid® Treatment Followed by Tollovid™ Dietary Supplementation
Published: 2022-07-22 (Crawled : 14:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M

Manufacturing

| -98.33% | O: 0.0% H: 2.5% C: -2.5%
paxlovid treatment covid study

Todos Medical Reports Case Study #7 in Acute and Long COVID
Published: 2022-07-12 (Crawled : 14:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M

Manufacturing

| -98.33% | O: -1.67% H: 5.08% C: 1.69%
covid study

Long COVID Evidence Begins to Mount, Suggesting Biomarkers and a "Triangle" Effect
Published: 2022-07-11 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -17.09% | O: -0.47% H: 0.0% C: 0.0%
covid biomarkers

Boston Researchers Identify Blood Biomarker for Long COVID
Published: 2022-07-11 (Crawled : 12:20) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -17.09% | O: -0.47% H: 0.0% C: 0.0%
blood covid biomarker

Long COVID Mental Health Symptoms
Published: 2022-07-11 (Crawled : 11:00) - brainsway.com
BWAY | $4.835 0.94% 0.93% 41K

Health Technology

| -5.07% | O: 5.26% H: 0.93% C: -7.22%
covid health

Todos Medical Releases Preliminary Data From IRB-Waived Tollovid® Market Research Study in Acute and Long COVID
Published: 2022-06-23 (Crawled : 12:00) - biospace.com/
TOMDF | $0.0001 100.0% 14M

Manufacturing

| -98.39% | O: 2.42% H: 9.45% C: 1.57%
tollovid research covid market

Global Roundup: Clover's COVID-19 Vaccine Booster Reaches Phase III
Published: 2022-06-16 (Crawled : 13:20) - biospace.com/
CNTG | $0.463 0.43% 0.43% 79K

Commercial Services

| -80.59% | O: -6.54% H: 5.64% C: 5.64%
covid-19 vaccine covid

The Maltese Islands Reopen for Summer, COVID-19 Restrictions Removed
Published: 2022-06-14 (Crawled : 09:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -60.99% | O: -2.13% H: 1.45% C: -1.45%
covid-19 covid

Research Roundup: Gene Regulation and Longevity, Comparing COVID-19 Vaccines
Published: 2022-06-03 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology